Insulet Corporation Net Income per Employee (PODD), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Insulet Corporation  (NASDAQ: PODD)
 

Insulet Net Income per Employee

PODD's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 322.22% in the second quarter 2026, year on year to cumulative value of $375 million, and with 5,400 employees, Insulet's income per employee grew on trailing twelve month basis to $ 69,500, this is below the company average income per employee.
The Healthcare sector has seen employees of 24 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 1290, from total ranking in previous quarter at 1696.


What is Income per Employee Ratio?






PODD Net Income per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Net Income Change 322.22 % 157.34 % 0.89 % 13.03 % -88.07 %
Net Income per Employee (TTM) $ 69,500 56,074 45,759 45,593 43,722
PODD's Total Ranking # 1290 # 1696 # 1421 # 1413 # 1041
Seq. Net Income Change 4.28 % -10.33 % 15.98 % 289.33 % -36.44 %


PODD Net Income per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 25
Healthcare Sector # 114
Overall Market # 1290

Net Income per Employee Statistics
High Average Low
$ 77,944 $ 8,871 $ -13,735
(Sep 30 2024)   (Mar 31 2016)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Collegium Pharmaceutical Inc   113,274.23 $ 47.915  Million 423 
Ani Pharmaceuticals Inc  109,895.88 $ 106.599  Million 970 
Entera Bio Ltd   109,500.00 $ 2.409  Million 22 
Idexx Laboratories Inc  103,605.09 $ 1,139.656  Million 11,000 
Lemaitre Vascular Inc   103,320.61 $ 67.675  Million 655 
Progyny Inc   91,860.98 $ 78.633  Million 856 
Globus Medical Inc   89,238.50 $ 535.431  Million 6,000 
Protalix Biotherapeutics inc   83,827.43 $ 18.945  Million 226 
Agilent Technologies inc   79,558.01 $ 1,440.000  Million 18,100 
Alpha Pro Tech Ltd   79,325.20 $ 9.757  Million 123 
Medpace Holdings Inc   79,274.19 $ 491.500  Million 6,200 
Aveanna Healthcare Holdings Inc   78,503.43 $ 274.762  Million 3,500 
Corcept Therapeutics Inc  74,261.64 $ 54.211  Million 730 
Solventum Corporation  71,700.00 $ 1,434.000  Million 20,000 
Insulet Corporation  69,500.00 $ 375.300  Million 5,400 
Strata Critical Medical Inc   66,923.46 $ 40.221  Million 601 
Stryker Corp  66,589.29 $ 3,729.000  Million 56,000 
Pro dex Inc   66,320.39 $ 13.662  Million 206 
Bioventus Inc   65,398.94 $ 61.475  Million 940 
Edwards Lifesciences Corporation  62,725.00 $ 1,003.600  Million 16,000 
Bio techne Corp  60,620.67 $ 181.862  Million 3,000 
Msa Safety Inc  59,246.98 $ 314.009  Million 5,300 
Pfizer Inc  58,266.67 $ 4,370.000  Million 75,000 
Sbc Medical Group Holdings Incorporated  57,479.19 $ 49.605  Million 863 
Electromed Inc   57,365.48 $ 11.301  Million 197 
Utah Medical Products Inc  57,300.55 $ 10.486  Million 183 
Livanova Plc  57,137.27 $ 188.553  Million 3,300 
Medtronic Plc  55,463.16 $ 5,269.000  Million 95,000 
Beone Medicines Ltd   54,642.25 $ 655.707  Million 12,000 
Mettler toledo International Inc   54,554.88 $ 905.611  Million 16,600 


Date modified: 2026-09-11T09:47:18+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.